Insider Selling: CRISPR THERAPTC (CRSP) CEO Sells 50000 Shares of Stock – Stock Observer
|
Insider Selling: CRISPR THERAPTC (CRSP) CEO Sells 50000 Shares of Stock
Stock Observer CRISPR THERAPTC logo CRISPR THERAPTC (NASDAQ:CRSP) CEO Rodger Novak sold 50,000 shares of the stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $16.26, for a total value of $813,000.00. CRISPR Therapeutics AG (:CRSP) Shares Tick 1.44% For the Week … Crispr Therapeutics AG (CRSP) Expected to Announce Earnings of … |
